ME1DB logo

Melodiol Global Health ASX:ME1DB Stock Report

Last Price

AU$0.005

Market Cap

AU$3.4m

7D

0%

1Y

n/a

Updated

07 Feb, 2024

Data

Company Financials

Melodiol Global Health Limited

ASX:ME1DB Stock Report

Market Cap: AU$3.4m

ME1DB Stock Overview

Engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific.

ME1DB fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Melodiol Global Health Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Melodiol Global Health
Historical stock prices
Current Share PriceAU$0.005
52 Week HighAU$0.005
52 Week LowAU$0.002
Beta2.66
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-98.76%

Recent News & Updates

Recent updates

Shareholder Returns

ME1DBAU PharmaceuticalsAU Market
7D0%-3.9%1.8%
1Yn/a56.8%10.8%

Return vs Industry: Insufficient data to determine how ME1DB performed against the Australian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how ME1DB performed against the Australian Market.

Price Volatility

Is ME1DB's price volatile compared to industry and market?
ME1DB volatility
ME1DB Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement8.6%
10% most volatile stocks in AU Market16.3%
10% least volatile stocks in AU Market3.2%

Stable Share Price: ME1DB's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine ME1DB's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015n/aWill Laymelodiolglobalhealth.com

Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser.

Melodiol Global Health Limited Fundamentals Summary

How do Melodiol Global Health's earnings and revenue compare to its market cap?
ME1DB fundamental statistics
Market capAU$3.42m
Earnings (TTM)-AU$53.94m
Revenue (TTM)AU$11.68m

0.3x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ME1DB income statement (TTM)
RevenueAU$11.68m
Cost of RevenueAU$14.02m
Gross Profit-AU$2.34m
Other ExpensesAU$51.61m
Earnings-AU$53.94m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.21
Gross Margin-20.00%
Net Profit Margin-461.80%
Debt/Equity Ratio115.9%

How did ME1DB perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.